PKM and cancer: Mutp53(N340Q/L344R) can also promote hepatocarcinogenesis through the upregulation of PKM2 by forming a complex with the long non-coding cancer-upregulated drug-resistant (CUDR) RNA, which binds to the promoter region of the pkm gene and stimulates the expression, phosphorylation and formation of PKM2 tetramer [455].